Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
John Phineas O’Donnell
,
Crochan J O’Sullivan
Added:
3 years ago
The demand for replacing degenerated bioprosthetic valves (BPVs) is steadily rising owing to the increasing burden of heart disease, ageing populations, advances in surgical intervention and limited durability of current-generation surgical BPVs. The issue is exacerbated by the increasing trend of surgical BPV replacement, especially in younger patients who are likely to require future…
View more
Author(s):
Mayra Guerrero
Added:
4 years ago
Dr Mayra Guerrero (Mayo Clinic Hospital, Rochester, US) discusses Mitral Valve-in-Valve: 1-year outcomes of transcatheter mitral valve replacement for degenerated mitral bioprotheses.
Questions :
1. What is the Mitral Valve-in-Valve study?
2. What is the next step to improve outcomes for this patient cohort?
Filmed on site at TCT 2019 by Radcliffe Cardiology
Videographer: Josh Birch…
View more
Author(s):
John T Saxon
,
Keith B Allen
,
David J Cohen
,
et al
Added:
3 years ago
Surgical aortic valve replacement (SAVR) has long been the standard of care for aortic valve replacement. More recently, transcatheter aortic valve replacement (TAVR) has been established as a safe, effective and less invasive method of valve replacement in patients with severe aortic stenosis who are at intermediate or high risk for complications related to SAVR.1–4 For patients who present with…
View more
Author(s):
Vinayak Bapat
,
Simon Kennon
Added:
8 years ago
The Fortis Valve Mitral Valve Trnascatheter Heart Valve: CE Mark Trial Update
Simon Kennon and Vinayak Bapat at EuroPCR 2015
View more
Valve-in-valve TAVR
Author(s):
Emily Perdoncin
,
Gaetano Paone
,
Isida Byku
Added:
1 year ago
Article
Author(s):
Roberto Spina
,
Chris Anthony
,
David WM Muller
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high…
View more
Author(s):
Ren Jie Yao
,
Matheus Simonato
,
Danny Dvir
Added:
3 years ago
In the context of an ageing population, care for valvular disease is becoming an increasingly important field. A recent large-scale population-based study found the prevalence of valvular disease to be 8.5 % in the 65–74-year-old group and 13.2 % in those over 75 years. 1 While mechanical surgical valves are more durable, bioprosthetic valves are often used as they are less thrombogenic and do…
View more
Hong Kong Valve 2018
Start date:
Sep 15, 2018
End date:
Sep 16, 2018
Event
Author(s):
Christian Spies
,
Ziyad M Hijazi
Added:
3 years ago
Unlike the left-sided semi-lunar valve, clinically significant acquired pulmonary valve disease is rare. However, stenotic or regurgitant pulmonary valve lesions are not uncommon following surgery for congenital heart defects, including tetralogy of Fallot, pulmonary atresia and other surgical procedures requiring reconstruction of the right ventricular outflow tract (RVOT).1–4 Even with the use…
View more